$13.070
-0.647 (-4.95%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CADL Prediction & Forecast by Similar Chart Analysis
Alphio's CADL stock price prediction model matches the current Candel Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.10 (+0.23%). The 1-week path is $13.34 (+2.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Candel Therapeutics Inc Stock?
Candel Therapeutics Inc is a good buy right now due to its recent clinical trial success, which showed a 50% survival rate beyond 24 months for patients, and a significant YTD change of +140.26%. The current price of $13.07 is well below the analyst price targets of $26 and $30, indicating substantial upside potential. However, the main risk is the company's negative earnings per share of -0.35 reported in the last quarter, which reflects ongoing financial challenges.
CADL stock price ended at $13.07 on Friday, after losing -4.95%
Candel Therapeutics Inc (CADL) last closed at $13.07, losing -4.95%. These facts feed the 1-day and 1-week CADL price prediction above.
Forecast Drivers
Candel Therapeutics Inc (CADL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CADL, ranked by similarity.
Seasonality analysis for CADL
Historically the probability of a positive August return for CADL is 66.67%. May offers the highest probability of a positive month at 66.67%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CADL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $6.43 | $7.43 | $7.93 | -43.14% |
| Sep 2026 | $5.16 | $6.02 | $6.92 | -53.98% |
| Oct 2026 | $7.77 | $8.05 | $8.49 | -38.40% |
| Nov 2026 | $6.74 | $7.31 | $7.61 | -44.08% |
| Dec 2026 | $7.43 | $7.57 | $8.02 | -42.04% |
In 2026, Candel Therapeutics Inc (CADL) is projected to range from $5.16 to $8.49.
Candel Therapeutics Inc 2026 monthly forecast
In Aug 2026, Candel Therapeutics Inc is projected to average $7.43, with a low of $6.43 and high of $7.93.
In Sep 2026, Candel Therapeutics Inc is projected to average $6.02, with a low of $5.16 and high of $6.92.
In Oct 2026, Candel Therapeutics Inc is projected to average $8.05, with a low of $7.77 and high of $8.49.
In Nov 2026, Candel Therapeutics Inc is projected to average $7.31, with a low of $6.74 and high of $7.61.
In Dec 2026, Candel Therapeutics Inc is projected to average $7.57, with a low of $7.43 and high of $8.02.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.